Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnesium sulfate: the first-line tocolytic.

David F Lewis1

  • 1Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, 71130-3932, USA.

Obstetrics and Gynecology Clinics of North America
|August 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the Molecular Pathways of Insulin-Producing Cells Derived From Placenta Multipotent Stem Cells via Multi-Omics Analysis.

Proteomics·2026
Same author

Comparative proteomic analysis of placental trophoblasts from normotensive and preeclamptic pregnancies in response to vitamin D.

Placenta·2025
Same author

Increased DNA damage/repair response in placentas from women infected with COVID-19 in pregnancy.

Placenta·2025
Same author

Altered Production and Cellular Levels of Hydrogen Sulfide (H<sub>2</sub>S) in Placental Trophoblasts from Pregnancies Affected by Pre-Eclampsia.

Pathophysiology : the official journal of the International Society for Pathophysiology·2025
Same author

Venous vs capillary glucose for gestational diabetes screening: a comparative study.

American journal of obstetrics & gynecology MFM·2024
Same author

Investigation of dosimetric characteristics of radiochromic film in response to alpha particles emitted from Americium-241.

Medical physics·2024

Magnesium sulfate is a common treatment for preterm labor due to its ease of use and safety. Further research is needed to understand the underlying causes of preterm labor and optimize treatments.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology

Background:

  • Magnesium sulfate is the primary short-term tocolytic agent for idiopathic preterm labor.
  • Its widespread use is attributed to familiarity, ease of administration, and a favorable maternal safety profile.
  • Evidence supports its efficacy, particularly at higher dosages.

Purpose of the Study:

  • To review the current status of magnesium sulfate as a tocolytic agent.
  • To highlight the shift in focus towards understanding the fundamental causes of preterm labor.
  • To emphasize the need for further research into magnesium sulfate's clinical applications and the etiology of preterm labor.

Main Methods:

  • Literature review of existing studies on magnesium sulfate for preterm labor.
  • Analysis of current clinical practices and research trends in tocolysis.

Related Experiment Videos

  • Identification of knowledge gaps regarding the causes and management of preterm labor.

    • Main Results:

    • Magnesium sulfate is established as a first-line tocolytic for short-term management of preterm labor.
    • Efficacy is demonstrated, especially with higher doses.
    • The focus is increasingly on identifying specific causes of preterm labor for tailored treatments.

    Conclusions:

    • While magnesium sulfate is effective and safe for short-term preterm labor, understanding its fundamental causes is crucial.
    • Tailored treatment protocols based on specific etiologies are essential for future management.
    • Further scientifically rigorous research is required to address key clinical questions surrounding magnesium sulfate and preterm labor.